Experts Mull How Life Sciences Firms Can Prep for ‘New Normal’

The COVID-19 pandemic has dramatically altered health care delivery patterns. Hospitals have had to exhaust their resources caring for COVID patients, while other important health care services, like cancer screening, have taken a back seat.

While the pandemic is not over, vaccination efforts continue and lockdown orders have eased, allowing experts the chance to look back at how the pandemic has affected the patient journey and what this means for a post-pandemic world. Health care stakeholders, including life sciences companies, are starting to ask about lessons learned and what changes need to be made to provide better patient support.

© 2023 MMIT
Freelance Reporter

Freelance Reporter Freelance Reporter

Related Posts

bills-and-pills
January 26

Medicare Enrollees May Still Face Affordability Issues After Part D Benefit Redesign

READ MORE
pills-in-hand
January 26

ICER Report Aims to Nudge Payers Toward Fairer Drug Coverage Policies

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
January 26

News Briefs: Lilly Alzheimer’s Drug Fails to Win Accelerated Approval

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today